This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

MEMPHIS, Tenn. — Mylan Pharmaceuticals announced it’s now recalling all lots of Valsartan-containing medications.

This is an expansion of a recall from two weeks ago of the blood pressure medication.  The pills contain an impurity that’s considered a “probable carcinogen.”

The expanded recall covers 104 additional lots including various strengths and bottles of the following:

  • Amlodipine and Valsartan Tablets
  • Valsartan Tablets
  • Valsartan and Hydrochlorothiazide Tablets

The medications were distributed in the U.S. between March 2017 and November 2018.

Mylan’s recall of medications containing Valsartan is one of many this year. Several other companies have recalled medications containing Valsartan due to the same problem.

The Food and Drug Administration has been maintaining lists of “drugs under recall” and those “not under recall.”

Patients who take Valsartan on a recalled list should talk with their doctor or pharmacist about an alternative.